Chrissy Metz Discloses GLP-1 Use Amid Shift in Weight Management Approach
"This Is Us" actress Chrissy Metz has begun using GLP-1 medication to assist with her health journey, citing long-term struggles with weight and persistent "food noise." Metz, 45, is partnering with the telehealth company Ro to manage her treatment, marking a departure from her previous skepticism toward the drug class. According to statements provided to E! News and People, the actress turned to the medication after finding that traditional methods—including diets and therapy—did not yield the sustainable results she required while navigating perimenopause and a family history of obesity.
Addressing ‘Food Noise’ and Physical Mobility
For Metz, the primary benefit of the GLP-1 treatment has been the reduction of "food noise," which she describes as the constant, intrusive thoughts about eating that persisted even while she was consuming a meal. Beyond the psychological impact, Metz reports tangible physical improvements. She told E! News that the medication has helped decrease joint pain and inflammation, providing her with the mobility necessary to perform on stage in the Broadway production of "& Juliet."
Her decision to start the medication followed what she termed "thorough research" conducted by a friend, which helped her understand how the drug might interact with her specific health profile. This contrasts with her earlier stance; Metz noted that she had been "very skeptical" of GLP-1s for approximately six years, dating back to the onset of the COVID-19 pandemic.
Public Scrutiny and Personal Health History
Metz has frequently been the subject of public commentary regarding her weight, a reality she says she has learned to navigate by tuning out outside opinions. "Listen, when it comes to me, everybody is judgy," Metz told E! News. She emphasized that critics are not aware of her medical history or the specific health challenges within her family.
This transition in her health regimen follows a long history of public openness regarding her body image and past trauma. In her 2018 memoir, This Is Me: Loving the Person You Are Today, and during an appearance on "The Jamie Kern Lima Show" podcast, Metz detailed experiencing physical and emotional abuse from her stepfather. She described being weighed in the kitchen and subjected to threats regarding food, which she characterized as a source of long-term trauma that influenced her relationship with eating.
Differing Approaches to Weight Loss
While Metz’s recent disclosure focuses on her integration of GLP-1 medication, reporting from other outlets highlights her long-term engagement with holistic health habits. According to EthnicityCeleb.com, Metz has previously credited her weight management to a combination of mindful eating, portion control, and consistent, gentle movement like daily 20-minute walks.
The actress has clarified that her previous weight loss efforts were not mandated by professional contracts, such as her work on This Is Us, but were personal decisions made to prioritize her well-being. By moving toward a combination of medical intervention and lifestyle habits, Metz aims to address the health factors that have proven resistant to previous, strictly non-medical attempts at weight loss.
Frequently Asked Questions
What is the "food noise" that Chrissy Metz describes?
"Food noise" is a term commonly used to describe persistent or intrusive thoughts about eating. Metz stated that the GLP-1 medication has helped silence these thoughts, allowing her to stop obsessing over her next meal.
Why did Chrissy Metz choose to start GLP-1 medication?
Metz stated she decided to start the medication because she is "not getting any younger" and was struggling with perimenopause and a family history of obesity. She noted that traditional diets and therapy had not provided the long-term results she was seeking.
Is Chrissy Metz working with a specific company for her health journey?
Yes, Metz is partnering with Ro, a digital health company that facilitates online medical appointments and the delivery of treatments.
How has the medication affected her professional life?
Metz reported that the reduction in joint pain and inflammation has improved her mobility, which she says has been beneficial for her current role as Angélique in the Broadway production of "& Juliet."
Chrissy Metz has been open about the emotional roots of her relationship with food, noting that she often ate due to feelings of sadness and depression rather than physical hunger, as reported by EthnicityCeleb.com.
Have you or someone you know navigated the complexities of weight management? Share your thoughts in the comments below or join our health community newsletter for more updates on wellness and medical trends.
Keep reading